BullishMEDIUM severityEarnings4h ago

Medicenna Therapeutics GAAP EPS of -$0.04 beats by $0.02

Medicenna Therapeutics GAAP EPS of -$0.04 beats by $0.02 — $MDNAF one-month chart
$MDNAF daily closes over the past month · Wook of Wall Street artwork from market data

At a glance

WOOK’s read

Health Care sector calm today, but $MDNAF slumped 37.41% to $0.16, near its 52-week low. The stock sits at 0% of its 52-week range, within a tenth of its low, despite a bullish coverage burst in the last week.

Written by Wook AI Nov 17, 3:54 PM ET from this page’s own figures at that time — not from the article — with every number checked against them. Not investment advice.

WOOKAI ASSISTANTREADY
WOOK AIASK ANYTHING · NEVER ADVISES

Ask about MDNAF. Get explanations, comparisons and calculations with the source lookups shown.

Risk check · medicennaEvent risk Low

Nothing reported about medicenna across key-person, legal, regulatory, security, operational or financial-integrity risk in three weeks of coverage and 30 days of SEC filings.

From here · last month’s volatility 155% a year
Now $0.160Week $0.125–$0.195 (±21.9%)Month $0.0882–$0.232 (±44.9%)
Ask Wook AI

Ranges are one standard deviation of volatility around the latest close — about 1 week in 3 moves further. Not a forecast or investment advice.

Wook analysis

What it means

Key points
  • What to watch: The headline hangs on one number ($0.04) — one data point is a snapshot, so the trailing trend is the context it needs.
  • How the stock is trading: $MDNAF -37.25% in the latest session.
  • Timing: It came out during market hours, so traders could react the same day, and the session move may reflect that.
Amount$0.04
Amount$0.02

Where the stock stands

Medicenna Therapeutics ($MDNAF) plunged 37.25% to $0.16 in the latest session. Over the past month it is down 42.7%. It now sits 88% under the 52-week high of $1.30 and 0.3% above the year's low of $0.16, close to the bottom of its range. It has been a volatile year: the high was 8.1 times the low, so moves this size are not unusual for it.

How much coverage it is getting

Wook has no other story on Medicenna Therapeutics from the last 30 days, so there is no recent run to compare this one with.

The bigger picture

With earnings, the number matters less than the number versus expectations — and guidance often matters more than both. A beat paired with a soft outlook can still get a cold reception. Health Care reads calm on Wook's supply-chain scanner today, with no unusual stress in the filings and disclosures it watches.

What to watch next

For the company's side of it, read its latest SEC filings on the $MDNAF page. A US company has to report material news on an 8-K, usually within four business days; foreign issuers use a 6-K. Where several outlets agree is usually the news; where they differ is the angle. Wook AI, at the top of the page, can work out how far $MDNAF is from its high or compare this week's coverage with earlier weeks.

Discussion

No one has weighed in yet. Start the discussion on this story.

What happened after this published

Seeking Alpha published this on November 17, 2026. $MDNAF has moved +0.00% ($0.16 to $0.16). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.

Headline and link are attributed to Seeking Alpha. Wook of Wall Street is an independent research tool and is not affiliated with Seeking Alpha. Nothing here is financial advice or a recommendation — research and educational content only.

Choose what Wook may measure. Essential sign-in and security cookies stay on.

Read the privacy policy